| Name | Title | Contact Details |
|---|
Focus on joint success We are one of the international market and technology leaders for innovative laser marking systems. As a global brand and technology center for laser marking solutions, we are part of the Product Quality and Identification segment of the publicly traded Veralto Corporation. FOBA is a leader in camera-based precision systems, machines and workflows for laser marking and engraving. We help our customers to ensure the traceability of their products, to protect their quality and brands, to design products and to respond to trends and regulations at an early stage – especially in our key markets of medical technology and the automotive, aerospace and electronics industries. With decades of laser application expertise, technology leadership in camera-assisted laser marking and consistent customer and service orientation, we can refer to several thousand successfully installed systems worldwide. https://www.fobalaser.com Imprint: https://www.fobalaser.com/legal-notice/ FOBA Laser Marking + Engraving Brand of ALLTEC Angewandte Laserlicht Technologie GmbH
DREAMSTAGE is a New York-based video streaming platform that allows artists to perform virtual musical concerts.
We are a community bank focused on doing whats best for our customers -- whether its providing a new service that works for more people, or taking the time to ask what more we can do to help. We offer every convenience for banking off-site or on-line, but never, ever compromise on personal attention. And proud as we are of our history dating back to 1868, our sights are firmly -- and optimistically -- set on whats ahead. Gorham Savings Bank is dedicated to improving the economic and social well-being of our customers and the communities we serve and committed to be the leading financial service provider in creating economic growth, prosperity, and financial security for the citizens and communities of Southern Maine by: • Developing and delivering quality products and services to our customers. • Establishing a workplace environment that attracts and retains highly motivated, high performing employees. • Achieving sound financial results which will allow us to reinvest in our company and in our communities in a meaningful and sustainable manner. Member FDIC - Equal Housing Lender
For information on open opportunities, review our job posting or email HR@AspirePartnersUSA.com
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.